Navigation Links
Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
Date:10/12/2007

Cold Spring Harbor, NY Gregory J. Hannon, Ph.D., Cold Spring Harbor Laboratory (CSHL) professor and Howard Hughes Medical Institute (HHMI) investigator, along with two other young investigators will be the recipients of the Memorial Sloan-Kettering Cancer Centers (MSKCC) 2007 Paul Marks Prize for Cancer Research.

The prize, named after Paul A. Marks, Ph.D., President Emeritus of MSKCC, recognizes significant contributions to the basic understanding and treatment of cancer by scientists no more than 45 years old at the time they are nominated. The winners were selected by a committee chaired by Jeffrey M. Friedman, M.D., Ph.D., a professor at The Rockefeller University. Each receives a medal and share a cash award of $150,000.

It is important to show appreciation for the work of younger scientists while they are still in the early stages of their careers, said Dr. Friedman. The Paul Marks Prize pays tribute to the man for whom it was named by honoring some of the most promising researchers of the next generation.

Dr. Hannon is a leader in the relatively new field of RNA interference (RNAi), a naturally occurring mechanism for regulating the expression of genes (controlling which genes are turned on and turned off in cells). In the laboratory, it is used as a tool to study the function of specific genes, and its being investigated as a therapeutic approach for treating many different diseases, including cancer.

Greg Hannons discoveries have had a broad impact on research related to the field of small RNA biology, said Bruce Stillman, Ph.D., CSHL President. As a leader in the RNAi field, Gregs work has resulted in the identification of a process that can manipulate gene expression, leading to a greater understanding of gene function, and identifying potential therapeutic drug targets.

Dr. Hannon earned his Ph.D. degree in molecular biology from Case Western Reserve University.

The Paul Marks Prize was established in 2001 and is awarded biennially. This years winners Hannon, Angelika Amon, Ph.D., of the Massachusetts Institute of Technology (MIT) and the Howard Hughes Medical Institute (HHMI), and Todd R. Golub, M.D., of the Dana-Farber Cancer Institute, the Broad Institute of Harvard and MIT, and the HHMI will speak about their work at a public symposium held at Memorial Sloan-Kettering Cancer Center on December 6, 2007.

Each investigator we are honoring is already a leader in his or her respective field, said Harold Varmus, M.D., MSKCC President. These scientists have made major contributions to the biological understanding of cancer, shedding light on what causes cancer and offering promising solutions that may someday provide benefits to patients everywhere.

In addition to Dr. Friedman, other members of the selection committee were Joan S. Brugge, PhD, of the Department of Cell Biology at Harvard Medical School; Titia de Lange, PhD, of The Rockefeller University; Stephen J. Elledge, PhD, of the Department of Biochemistry at Baylor College of Medicine; Stephen P. Goff, PhD, of the Department of Microbiology at Columbia University; Alan Hall, PhD, of the Cell Biology Program in the Sloan-Kettering Institute; Scott W. Lowe, PhD, of the Cold Spring Harbor Cancer Center; and William G. Kaelin Jr., MD, of the Dana-Farber Cancer Institute.


'/>"/>

Contact: Jim Bono
bono@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

Related biology news :

1. Neuronal traffic jam marks early Alzheimers disease
2. New gene scanning technology marks a major advance in disease research
3. Novel molecular signature marks DNA of embryonic stem cells
4. Scientists map key landmarks in human genome
5. LEGO-Like building blocks to halt cell growth wins Hebrew University prize
6. Comments, experts and background on the 2006 Nobel Prize in chemistry
7. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
8. Australian wins prestigious prize in biodiversity informatics
9. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
10. Zebrafish may hold key to understanding human nerve cell development
11. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/25/2016)... BELL, Pa. , Jan. 25, 2016   Unisys Corporation ... recognition system at John F. Kennedy (JFK) International Airport, ... Border Protection (CBP) identify imposters attempting to enter ... do not belong to them. pilot testing of ... out initially at three terminals at JFK during January 2016. ...
(Date:1/21/2016)... January 21, 2016 ... new market research report "Emotion Detection and Recognition Market by ... Tools (Facial Expression, Voice Recognition and Others), Services, ... forecast to 2020", published by MarketsandMarkets, the global ... reach USD 22.65 Billion by 2020, at a ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 4, 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an ... monetization of intellectual property, today provided an update on ... Northern District of Texas and ... Inter Partes Re-examination ("IPR") proceedings that VTech ... IPR was initiated on only certain claims of two ...
(Date:2/4/2016)... Strasbourg, France , to the US ... Strasbourg, France , to the US company Advanced Bioscience ... announce that it acted as an advisor to Transgene on ... Strasbourg, France , to the US company Advanced Bioscience ... Transgene (Euronext: TNG), a member of Institut Mérieux, is ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
(Date:2/3/2016)... YORK and HOLLISTON, Mass., Feb. 3, 2016 ... HART ), a biotechnology company developing bioengineered ... trachea and bronchus, today announced that CEO ... BIO CEO & Investor Conference on Tuesday, ... New York City . HART,s ...
Breaking Biology Technology: